Inclusion Criteria:~1. Clinical diagnosis of mild cognitive impairment (MCI), or dementia of Alzheimer's
type~2. Amyloid positivity established with either amyloid positron emission tomography or cerebrospinal fluid
analysis.~3. For subjects with dementia, the disease should be in an early stage, operationalized as:~ * Stage
4 (Mild dementia) or lower, according to the National Institute on Aging - Alzheimer's Association 2018
clinical staging criteria, AND~ * Clinical Dementia Rating Scale (CDR) global score of 1 or lower, AND~ *
Montreal Cognitive Assessment (MoCA) score of â‰¥ 18 OR Rey Auditory Verbal Learning Test (RAVLT) >4 words after
30 minutes~4. Capable of giving, and has the capacity to give informed consent~5. Availability of a responsible
study partner who can accompany the subject to all planned visits~6. Male or female between 50 and 80 years~7.
Normal or clinically acceptable medical history, physical examination, and vital signs~
